Rising BioSciences, Inc.

RBII

US76761W1080

Entertainment Production

Market Closed - OTC Markets Other stock markets 01:41:31 2024-04-11 pm EDT			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-.--%

2021	Rising BioSciences, Inc. acquired OXY THYME Southeast, Inc.	CI
2019	Rising BioSciences, Inc. acquired Southern Northern Behavioral Health, Inc.	CI

Rising Biosciences, Inc. Launches RBS0346 Clinical Strength Dulcis Stem Cell Cream on Amazon

July 02, 2018 at 11:00 am EDT

Rising Biosciences, Inc. announced that its revolutionary RBS0346 Clinical Strength Dulcis Stem Cell Cream will be available on Amazon.com in the coming days.

Latest news about Rising BioSciences, Inc.

Rising BioSciences, Inc. acquired OXY THYME Southeast, Inc.	21-04-27	CI
Rising BioSciences, Inc. acquired Southern Northern Behavioral Health, Inc.	19-06-03	CI
Rising Biosciences, Inc. Announces New Partnership with Three Seven Management	19-03-08	CI
Rising Biosciences, Inc. Launches RBS0346 Clinical Strength Dulcis Stem Cell Cream on Amazon	18-07-02	CI
Rising Biosciences Announces Official Sales and Distribution of its RSB0238 Clinical Strength Peptide Complex on Amazon	18-05-01	CI
Rising Biosciences, Inc. Launches TSW! Topicals Delivering Innovative Pain Relief to Market in Fourth Quarter	17-09-29	CI
Rising BioSciences, Inc. Initiates Testing for FDA Approval of OTC Chronic Pain Relief Medications	17-08-02	CI
Rising Biosciences, Inc. Announces Management Changes	17-04-27	CI
Rising BioSciences, Inc. signed a letter of intent to acquire Rising India INC. in a reverse merger transaction.	17-02-22	CI

Chart Rising BioSciences, Inc.

Duration

Period

More charts

Rising Biosciences, Inc. is a research and development company. The Company is focused on oral and topical cannabis and non-cannabis-based pharmaceuticals. The Company operates through three distinct business units. In addition to Oxi Thyme, the second business unit is a physicianâs practice management company focused on the proper use of cannabis for the treatment of chronic pain, opioid addiction, and terminal patients. The third business unit is a research and development company focused on oral and topical pharmaceuticals. Through its subsidiaries and investment holdings, the Company is focused on the treatment of individuals in both inpatient and outpatient environments recovering from alcohol and drug addiction.

Sector

Entertainment Production

More about the company

Sector Movie, TV Production & Distribution

	1st Jan change	Capi.
RISING BIOSCIENCES, INC.	-.--%	1.06K
ENDEAVOR GROUP HOLDINGS, INC.	+11.29%	7.98B
MANGO EXCELLENT MEDIA CO., LTD.	-6.98%	6.06B
TOHO CO., LTD.	+9.58%	5.75B
MADISON SQUARE GARDEN SPORTS CORP.	+2.16%	4.45B
FL ENTERTAINMENT N.V.	+9.47%	4.19B
BEIJING ENLIGHT MEDIA CO., LTD.	+14.85%	3.77B
CHINA FILM CO., LTD.	-2.78%	3.07B
CHINA RUYI HOLDINGS LIMITED	+13.87%	2.92B
ZHEJIANG HUACE FILM & TV CO., LTD.	+44.80%	2.2B

Movie, TV Production & Distribution